Rivaroxaban does not prevent cardiovascular events in rheumatic heart disease patients with atrial fibrillation
1. Rivaroxaban was not associated with a lower rate of cardiovascular events and death compared to vitamin K antagonist treatment ...
1. Rivaroxaban was not associated with a lower rate of cardiovascular events and death compared to vitamin K antagonist treatment ...
1. Early rhythm control for atrial fibrillation (AF) was associated with a significantly reduced risk of an adverse cardiovascular event. ...
1. The overall benefit of left atrial appendage occlusion (LAOO) for prevention of stroke in patients with atrial fibrillation (AF) ...
1. Comprehensive genetic testing for cardiomyopathy and arrhythmia diagnoses improved the ability to detect underlying conditions which may have otherwise ...
1. The Canadian Syncope Risk Score was superior when compared to the Osservatorio Epidemiologico della Sincope nel Lazio (OESIL) score ...
1. In junior athletes recovering from SARS-CoV-2 infection, cardiac complications were uncommon (3.2%) and not associated with malignant ventricular arrhythmias. ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.